Type III systemic allergic reaction to natalizumab

Arch Neurol. 2008 Jun;65(6):851-2; author reply 852. doi: 10.1001/archneur.65.6.851-b.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Adult
  • Antibodies / adverse effects
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Drug Eruptions / classification
  • Drug Eruptions / immunology
  • Drug Eruptions / pathology
  • Female
  • Humans
  • Hypersensitivity, Delayed / classification*
  • Hypersensitivity, Delayed / immunology*
  • Hypersensitivity, Delayed / pathology
  • Natalizumab

Substances

  • Antibodies
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab